Update in Cancer Chemotherapy: Genitourinary Tract Cancer, Part 2: Wilms' Tumor and Bladder Cancer

Overview

Journal J Natl Med Assoc

Publisher Elsevier

Specialty General Medicine

Date 1988 Feb 1

PMID 2853770

Citations 2

Authors

J C Wright

Affiliations

Soon will be listed here.

Abstract

An update of the state of the art of cancer chemotherapeutic treatment of genitourinary tract cancer is described in this multi-part series. Included in the review are cancers of the kidney, bladder, prostate, testicle, ovary, uterus, vulva, and gestational trophoblastic neoplasms. Part 2 focuses on Wilms' tumor and bladder cancer.Major advances have been made in the control of Wilms' tumor in children. The combination of surgery, chemotherapy, and radiotherapy have significantly improved survival rates. Likewise, the early diagnosis and control of bladder cancer has also improved survival. Surgery predominates among the treatment modalities for carcinoma of the bladder. Important progress is being made in the control of these conditions, as well as with other tumors of the genitourinary tract, with the use of cancer chemotherapy.

Citing Articles

Multidisciplinary Treatment Strategies for Wilms Tumor: Recent Advances, Technical Innovations and Future Directions.

Theilen T, Braun Y, Bochennek K, Rolle U, Fiegel H, Friedmacher F Front Pediatr. 2022; 10:852185.

PMID: 35911825 PMC: 9333359. DOI: 10.3389/fped.2022.852185.

Innovations in the management of Wilms' tumor.

Gleason J, Lorenzo A, Bowlin P, Koyle M Ther Adv Urol. 2014; 6(4):165-76.

PMID: 25083165 PMC: 4054506. DOI: 10.1177/1756287214528023.

References

Natale R, Yagoda A, Watson R, Whitmore W, Blumenreich M, Braun Jr D . Methotrexate: an active drug in bladder cancer. Cancer. 1981; 47(6):1246-50. DOI: 10.1002/1097-0142(19810315)47:6<1246::aid-cncr2820470603>3.0.co;2-g. View

Schwartz S, Yagoda A, Natale R, Watson R, Whitmore W, Lesser M . Phase II trial of sequentially administered cisplatin, cyclophosphamide and doxorubicin for urothelial tract tumors. J Urol. 1983; 130(4):681-4. DOI: 10.1016/s0022-5347(17)51401-9. View

Farber S . Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer. Blood. 1949; 4(2):160-7. View

Slack N, Bross I, Prout Jr G . Five-year follow-up results of a collaborative study of therapies for carcinoma of the bladder. J Surg Oncol. 1977; 9(4):393-405. DOI: 10.1002/jso.2930090410. View

Farber S, Pinkel D, SEARS E, TOCH R . Advances in chemotherapy of cancer in man. Adv Cancer Res. 1956; 4:1-71. DOI: 10.1016/s0065-230x(08)60721-6. View

Wilson W . Chemotherapy of human solid tumors with 5-fluorouracil. Cancer. 1960; 13:1230-9. DOI: 10.1002/1097-0142(196011/12)13:6<1230::aid-cncr2820130612>3.0.co;2-d. View

SKINNER D, Tift J, Kaufman J . High dose, short course preoperative radiation therapy and immediate single stage radical cystectomy with pelvic node dissection in the management of bladder cancer. J Urol. 1982; 127(4):671-4. DOI: 10.1016/s0022-5347(17)53986-5. View

LADD W . EMBRYOMA OF THE KIDNEY (WILMS' TUMOR). Ann Surg. 1938; 108(5):885-902. PMC: 1386999. DOI: 10.1097/00000658-193811000-00010. View

Prout Jr G . The surgical management of bladder carcinoma. Urol Clin North Am. 1976; 3(1):149-75. View

10.

Soloway M, Einstein A, Corder M, Bonney W, Prout Jr G, Coombs J . A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Collaborative Group A Study. Cancer. 1983; 52(5):767-72. DOI: 10.1002/1097-0142(19830901)52:5<767::aid-cncr2820520502>3.0.co;2-p. View

11.

Meyers F, Palmer J, Freiha F, Harker E, Shortliffe L, Hannigan J . The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study. J Urol. 1985; 134(6):1118-21. DOI: 10.1016/s0022-5347(17)47651-8. View

12.

Al-Sarraf M, Frank J, Smith Jr J, OBRYAN R, COSTANZI J, Stephens R . Phase II trial of cyclophosphamide, doxorubicin, and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: a Southwest Oncology Group study. Cancer Treat Rep. 1985; 69(2):189-94. View

13.

Muggia F, Hamza M, Sherif M, Mansour M, Khafagy M . Chemotherapeutic management of carcinoma of the bilharzial bladder: a phase II trial with hexamethylmelamine and VM-26. Cancer Treat Rep. 1978; 62(7):993-6. View

14.

Pizza G, Severini G, MENNITI D, De Vinci C, Corrado F . Tumour regression after intralesional injection of interleukin 2 (IL-2) in bladder cancer. Preliminary report. Int J Cancer. 1984; 34(3):359-67. DOI: 10.1002/ijc.2910340312. View

15.

Green D, Jaffe N . Wilms' tumor--model of a curable pediatric malignant solid tumor. Cancer Treat Rev. 1978; 5(3):143-72. DOI: 10.1016/s0305-7372(78)80018-8. View

16.

Wynder E, Goldsmith R . The epidemiology of bladder cancer: a second look. Cancer. 1977; 40(3):1246-68. DOI: 10.1002/1097-0142(197709)40:3<1246::aid-cncr2820400340>3.0.co;2-5. View

17.

JONES H, SWINNEY J . Thiotepa in the treatment of tumours of the bladder. Lancet. 1961; 2(7203):615-8. DOI: 10.1016/s0140-6736(61)90304-x. View

18.

DAngio G . Unexpected toxicity encountered in the National Wilms' Tumor Study. Cancer Treat Rep. 1987; 71(10):993. View

19.

van der Werf-Messing B . Cancer of the urinary bladder treated by interstitial radium implant. Int J Radiat Oncol Biol Phys. 1978; 4(5-6):373-8. DOI: 10.1016/0360-3016(78)90065-2. View

20.

Vietti T, Sullivan M, HAGGARD M, HOLCOMB T, Berry D . Vincristine sulfate and radiation therapy in metastatic Wilms' tumor. Cancer. 1970; 25(1):12-20. DOI: 10.1002/1097-0142(197001)25:1<12::aid-cncr2820250104>3.0.co;2-n. View